talenther

TOMORROW’S
INNOVATIONS TODAY'S NEEDS

Prime Biosciences is an innovative company offering high-end products and services in the healthcare industry

ABOUT US

FOCUSING ON PEOPLE'S LIVES AND STRONG PARTNERSHIPS

Prime Biosciences is a pioneering provider of a complete spectrum of services in the healthcare industry. The company was established in 2018 by top sales and marketing executives who possess extensive experience in the pharmaceutical sector in Europe and the US, with the aim to offer a comprehensive range of high-quality medical products.

DISCOVER

Therapeutic Areas

  • Peadiatrics
  • Intensive Care
  • Infectious disease
  • Orthopeadics
  • Allergology

Services

At Prime Biosciences, we aim to bridge the gap between medical advancement and patients’ needs. We represent and distribute parapharmaceutical products and high quality equipment, always based on the deep knowledge of the market and the current conditions. We focus on the provision of the best possible answers to particular patient and healthcare provider needs, while widening and strengthening the presence of our partners by making their products the leaders in the market.

We work closely with our partners in order to find all the needs faced by their products in local markets, with the primary goal of strengthening their presence and market share.

DISCOVER

THE PRODUCTS

05 February 2025

Participation of Prime Biosciences in the 44th Postgraduate Pediatric Seminar

 

Prime Biosciences participated dynamically in the 44th Postgraduate Pediatric Seminar, organized by the 2nd Pediatric Clinic of the University of Athens, Children's Hospital "P. & A. Kyriakou", which took place on November 2-3, 2024 at the Athens College amphitheater.

Participation of Prime Biosciences in the 44th Postgraduate Pediatric Seminar READ MORE
10 October 2024

Pancreatic Stone Protein (PSP) IVD Capsule test has been granted FDA 510(k) clearance

 

FDA 510(k) clearance for the Pancreatic Stone Protein (PSP) IVD Capsule test has been granted in order to accelerate the Time-to-Detection of Sepsis. This achievement is a huge milestone for this novel biomarker!

Pancreatic Stone Protein (PSP) IVD Capsule test has been granted FDA 510(k) clearance READ MORE